Acquirer | Target | Price |
---|---|---|
Celgene Corporation | Collaboration on immuno-oncology drugs | $225 million |
Santen Pharmaceutical Co. Ltd. | InnFocus Inc. | $225 million |
Zimmer Biomet Holdings | Medtech SA | $132.9 million |
Janssen Biotech | License to IONIS-JBI1-2.5Rx | $10 million |
Center Management Group, LLC | Assisted living community | $4.25 million |